PL409330A1 - Szczepy Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA - Google Patents

Szczepy Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA

Info

Publication number
PL409330A1
PL409330A1 PL409330A PL40933014A PL409330A1 PL 409330 A1 PL409330 A1 PL 409330A1 PL 409330 A PL409330 A PL 409330A PL 40933014 A PL40933014 A PL 40933014A PL 409330 A1 PL409330 A1 PL 409330A1
Authority
PL
Poland
Prior art keywords
staphylococcus aureus
production
plasmid dna
deprived
impurities
Prior art date
Application number
PL409330A
Other languages
English (en)
Other versions
PL236568B1 (pl
Inventor
Małgorzata Łobocka
Monika Hejnowicz
Kamil Dąbrowski
Dariusz Izak
Agnieszka Gozdek
Aleksandra Głowacka
Jan Gawor
Jarosław Kosakowski
Robert Gromadka
Beata Weber-Dąbrowska
Andrzej Górski
Original Assignee
Instytut Biochemii I Biofizyki Polskiej Akademii Nauk
Instytut Immunologii I Terapii Doświadczalnej Polskiej Akademii Nauk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Biochemii I Biofizyki Polskiej Akademii Nauk, Instytut Immunologii I Terapii Doświadczalnej Polskiej Akademii Nauk filed Critical Instytut Biochemii I Biofizyki Polskiej Akademii Nauk
Priority to PL409330A priority Critical patent/PL236568B1/pl
Priority to PCT/IB2015/056606 priority patent/WO2016030871A1/en
Priority to EP18195142.7A priority patent/EP3460048B1/en
Priority to EP15797403.1A priority patent/EP3186362B1/en
Priority to PL18195142T priority patent/PL3460048T3/pl
Publication of PL409330A1 publication Critical patent/PL409330A1/pl
Publication of PL236568B1 publication Critical patent/PL236568B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/44—Staphylococcus
    • C12R2001/445—Staphylococcus aureus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Ujawniono szczepy Staphylococcus aureus do otrzymywania monoklonalnych preparatów bakteriofagów litycznych o wysokim mianie, pozbawionych zanieczyszczeń niepożądanymi bakteriofagami oraz plazmidowym DNA, które gwarantują produkcję bezpiecznych w stosowaniu preparatów bakteriofagowych nie będących źródłem rozsiewu genów związanych z wirulencją bakterii. Korzystnie jest to szczep Staphylococcus aureus 80wphwpl zdeponowany w PCM jako B/00072 albo szczep Staphylococcus aureus 6409wphpl zdeponowany w PCM jako B/00073.
PL409330A 2014-08-31 2014-08-31 Szczepy Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA PL236568B1 (pl)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PL409330A PL236568B1 (pl) 2014-08-31 2014-08-31 Szczepy Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA
PCT/IB2015/056606 WO2016030871A1 (en) 2014-08-31 2015-08-31 Staphylococcus aureus strains for production of monoclonal phage preparations deprived of contamination with plasmid dna
EP18195142.7A EP3460048B1 (en) 2014-08-31 2015-08-31 Staphylococcus aureus strains for production of monoclonal phage preparations deprived of contamination with plasmid dna
EP15797403.1A EP3186362B1 (en) 2014-08-31 2015-08-31 Staphylococcus aureus strains for production of monoclonal phage preparations deprived of contamination with plasmid dna
PL18195142T PL3460048T3 (pl) 2014-08-31 2015-08-31 Szczep Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL409330A PL236568B1 (pl) 2014-08-31 2014-08-31 Szczepy Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA

Publications (2)

Publication Number Publication Date
PL409330A1 true PL409330A1 (pl) 2016-03-14
PL236568B1 PL236568B1 (pl) 2021-01-25

Family

ID=54601839

Family Applications (2)

Application Number Title Priority Date Filing Date
PL409330A PL236568B1 (pl) 2014-08-31 2014-08-31 Szczepy Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA
PL18195142T PL3460048T3 (pl) 2014-08-31 2015-08-31 Szczep Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL18195142T PL3460048T3 (pl) 2014-08-31 2015-08-31 Szczep Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA

Country Status (3)

Country Link
EP (2) EP3186362B1 (pl)
PL (2) PL236568B1 (pl)
WO (1) WO2016030871A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20201127T1 (hr) * 2012-04-26 2020-11-27 University Of Chicago Antigeni stafilokokne koagulaze i metode primjene istih
WO2019152657A1 (en) 2018-02-03 2019-08-08 Simple Healthkit, Inc. Reliable, comprehensive, and rapid sexual health assessment
WO2025217176A1 (en) * 2024-04-08 2025-10-16 Board Of Trustees Of Michigan State University Genetically engineered bacteria as a chassis host for high yield terpenoid production

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2012668A3 (cs) * 2012-09-27 2013-08-07 Imuna S.R.O. Lécivo ve forme antistafylokokového fágového lyzátu, zpusob jeho výroby a pouzití

Also Published As

Publication number Publication date
EP3460048A1 (en) 2019-03-27
EP3186362A1 (en) 2017-07-05
WO2016030871A1 (en) 2016-03-03
EP3460048B1 (en) 2021-04-28
PL236568B1 (pl) 2021-01-25
PL3460048T3 (pl) 2021-10-25
EP3186362B1 (en) 2019-05-15

Similar Documents

Publication Publication Date Title
PH12016502555A1 (en) Methods of preparing substituted nucleotide analogs
MY188541A (en) Besifloxacin for the treatment of resistant acne
MX2017008184A (es) Nucleosidos sustituidos, nucleotidos y analogos de estos.
MY176328A (en) Targeted mutations
WO2015153889A3 (en) Materials and methods for the treatment of latent viral infection
PH12017500296B1 (en) Anti-tigit antibodies
EA201891201A1 (ru) Композиции, содержащие бактериальные штаммы
WO2016033439A3 (en) Compositions and methods for the treating an inflammatory disease or disorder
EA201890050A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890049A1 (ru) Композиции, содержащие бактериальные штаммы
WO2015112896A3 (en) Methods and compositions for sequences guiding cas9 targeting
JOP20200157B1 (ar) أجسام مضادة ذات سلسلة ثقيلة ترتبط بـ cd22
MX2019004611A (es) Metodos y composiciones para cambiar la composicion del microbioma de la piel usando mezclas complejas de cepas bacterianas.
EA201790265A1 (ru) Способы получения тромбоцит-содержащих продуктов
PH12018500379B1 (en) Biopharmaceutical compositions
MY191539A (en) Streptococcal vaccine
TN2016000435A1 (en) Novel macrocyclic compounds.
EP3402872A4 (en) MILKIC ACID USE BACTERIA GENETICALLY MODIFIED TO POLYSACCHARIDE-DERIVED ENZYMES
MX2017016401A (es) Composiciones inmunogenas.
MX2019005535A (es) Streptococcus thermophilus para uso en la preparación de productos fermentados.
MX2018005872A (es) Profarmacos de acido nucleico.
WO2016100615A3 (en) Methods and composition for neutralization of influenza
PL409332A1 (pl) Szczepy Enterococcus faecalis do produkcji monoklonalnych preparatów fagowych
PL409330A1 (pl) Szczepy Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA
PH12017500820A1 (en) Combination long acting compositions and methods for hepatitis c